Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease

  • RnM3818116
    • |
  • 24 October, 2019
    • |
  • 55 Pages
    • |
  • GlobalData
    • |
  • Pharma & Healthcare

Make an enquiry before buying this Report



Purchase this Report

$6,995.00
$13,990.00
$20,985.00
5,281.23
10,562.45
15,843.68
6,141.61
12,283.22
18,424.83
994,479.15
1,988,958.30
2,983,437.45
599,261.65
1,198,523.30
1,797,784.95
Credit card Logo

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo